oxatomide has been researched along with Dermatitis in 1 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
Dermatitis: Any inflammation of the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxatomide is a new anti-allergy drug, derived from benzamidazole, which has shown original pharmacological properties at different stages of the degranulation of mastocytes and basophils, inhibition of the increase of intracellular calcium, inhibition of histamine release and of the synthesis of leukotrienes and prostaglandins." | 2.38 | [Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology]. ( Cabotin, PP; Janier, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabotin, PP | 1 |
| Janier, M | 1 |
1 review available for oxatomide and Dermatitis
| Article | Year |
|---|---|
[Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology].
Topics: Animals; Basophils; Calcium; Cell Degranulation; Dermatitis; Dogs; Histamine H1 Antagonists; Histami | 1990 |